Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Shandong Sinobioway Biomedicine Co Ltd (002581)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.22 +0.10    +1.40%
01/08 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE1000012Y5 
  • Volume: 9,628,300
  • Bid/Ask: 7.22 / 7.22
  • Day's Range: 7.08 - 7.36
Shandong Sinobioway Biomedicine 7.22 +0.10 +1.40%

Shandong Sinobioway Biomedicine Co Ltd Company Profile

 
Get an in-depth profile of Shandong Sinobioway Biomedicine Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

666

Equity Type

ORD

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates in China. The company manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, and trimethyl acetate and its by-products. It also offers Anfulan, a human interferon a2b injection; Jiefu, a human interferon a2b spray; Enjingfu, a mouse nerve growth factor for injection; and Bellaph, a combined hepatitis A and B vaccine. In addition, the company is involved in biopharmaceutical research and development services, including cell line development and cell bank building, cell culture process development, protein purification process development, preparation prescription and process development, analysis and detection method development, and quality research. Further, it provides biopharmaceutical production services, such as preclinical, clinical phase I/II/III and commercial manufacturing; and other services, including regulatory service support and drug registration affairs. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

Contact Information

Address Room 2005, No. 22 Keji South 12th Road
Shenzhen, 518057
China
Phone 86 75 5869 50185
Fax 86 75 5869 50185

Top Executives

Name Age Since Title
Wenjun Liu 41 2022 Deputy GM & Non-Independent Director
Xiuyuan Yu 62 2015 Vice Chair
Jialin Yue 56 2022 Chairman & GM
Jie Xiao 55 2022 Independent Director
Yang Xia 61 2022 Independent Director
Guiyuan Huang 33 2022 Non-Independent Director
Yue Ying 28 2023 Director
Wenjie Yu 46 2018 Director
Yang Liu 42 2022 Independent Director
Tiefu Liu 53 2023 Supervisory Board Chairman
Xue Ming Yan 52 2015 Member of the Supervisory Board
Xiaoru Shi - 2025 Non-Independent Director
Rongfu Zhang - 2025 Independent Director
Ying Ke 28 2023 Supervisor
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

002581 Comments

Write your thoughts about Shandong Sinobioway Biomedicine Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email